Viseon Gains FDA Clearance for Voyant Imaging for MIS Spine

Viseon  announced an additional FDA 510(k) clearance and initial clinical use of Voyant, an integration of minimally invasive surgical (MIS) access with real-time high-definition imaging technology. Limited launch will commence in 1Q20, with full market release to come in 2H20.

Viseon is a single-use, disposable alternative to surgical...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0